Delayed-type hypersensitivity skin reactions caused by subcutaneous unfractionated and low-molecular-weight heparins: tolerance of a new recombinant hirudin.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Journal of American Academy of Dermatology

• Publication date

  2000-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1067/MJD.2000.101595PMID 10727306
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Low molecular weight heparin

  2014cited by this paper
• [Heparin-associated platelet aggregation syndrome with skin necrosis during hemodialysis].

  2008cited by this paper
• Spättypreaktionen auf Heparine und Heparinoide : Hirudin als therapeutische Alternative : Eine Fallbeschreibung

  1998cited by this paper
• Spättyp-allergie auf heparine bei guter verträglichkeit von natriumpentosanpolysulfat

  1998cited by this paper
• Subcutaneous Recombinant Hirudin (HBW 023) Versus Intravenous Sodium Heparin in Treatment of Established Acute Deep Vein Thrombosis of the Legs: a Multicentre Prospective Dose-ranging Randomized Trial

  1997cited by this paper
• [Toxic dermatitis caused by heparin].

  1996cited by this paper
• Acute urticaria caused by subcutaneous recombinant hirudin: evidence for an IgG-mediated hypersensitivity reaction.

  1996cited by this paper
• Enoxaparin for Unstable Angina and Ancrod for Cardiac Surgery following Heparin Allergy

  1996cited by this paper
• Tolerance to intravenous admiration of heparin and heparinoid in a patient with delayed‐type hypersensitivity to heparins and heparinoids

  1996cited by this paper
• TOXIDERMIE A L'HEPARINE

  1996cited by this paper
• Type IV allergy to natural hirudin confirmed by in vitro stimulation with recombinant hirudin

  1996cited by this paper
• Delayed hypersensitivity to one low‐molecular‐weight heparin with tolerance of other low‐molecular‐weight heparins

  1995cited by this paper
• RECOMBINANT HUMAN ERYTHROPOIETIN THERAPY IN PATIENTS WITH MYELOFIBROSIS WITH MYELOID METAPLASIA

  1994cited by this paper
• Urticaria and angioedema induced by low-molecular-weight heparin.

  1992cited by this paper
• Tolerance of intravenous low‐molecular‐weight heparin after eczematous reaction to subcutaneous heparin

  1991cited by this paper
• Allergische Hautreaktionen gegen Standard-und niedermolekulare Heparine Gute Verträglichkeit von Heparin-Analogen

  1991cited by this paper
• Eczematous infiltrated plaques to subcutaneous heparin: a type IV allergic reaction

  1990cited by this paper
• Low Molecular Weight Heparin Treatment in a Pregnant Woman with Allergy to Standard Heparins and Heparinoid

  1989cited by this paper
• Eczema-like, erythematous, infiltrated plaques: a common side effect of subcutaneous heparin therapy.

  1989cited by this paper
• Delayed‐type hypersensitivity reaction to heparin

  1989cited by this paper
• [Treatment in a heparin-induced skin reaction with a low-molecular heparin analog].

  1984cited by this paper
• Behandlung bei heparin-induzierter kutaner Reaktion mit einem niedermolekularen Heparin-Analog

  1984cited by this paper

• A Case of an Allergic Contact Dermatitis Following the Administration of Enoxaparin: A Case Report and Review of the Literature

  2025cites this paper
• Medication Associations With Severe Cutaneous Adverse Reactions: A Case/Non-Case Analysis Using the FDA Adverse Event Reporting System

  2024cites this paper
• Traumatic Panniculitis-the Spectrum

  2021cites this paper
• Perioperative Anaestheisa

  2021cites this paper
• Practical Guidance for the Evaluation and Management of Drug Hypersensitivity: Specific Drugs.

  2020cites this paper
• Reacción cutánea alérgica tardía a heparinas. Revisión de la literatura a partir de un caso clínico

  2019cites this paper
• Adverse Drug Reactions and Cutaneous Manifestations Associated With Anticoagulation

  2017cites this paper
• Low-Molecular-Weight Heparins as Immunomodulators in Dermatology Practice

  2016cites this paper
• [A study of 19 cases of allergy to heparins with positive skin testing].

  2014cites this paper
• Patch Testing in Drug Eruptions

  2014cites this paper
• Subcutis calcinosis caused by injection of calcium-containing heparin in a chronic kidney injury patient.

  2014cites this paper
• Étude de 19 cas d'allergie aux héparines prouvée par des tests cutanés

  2014cites this paper
• High incidence of heparin-induced allergic delayed-type hypersensitivity reactions in pregnancy.

  2013cites this paper
• Hypersensitivity to Nadroparin Calcium Case Report and Review of the Literature

  2012cites this paper
• Adverse effects of heparin.

  2012cites this paper
• Heparin - A Century of Progress

  2012cites this paper
• Heparin-induced skin lesions.

  2012cites this paper
• The risk for cross‐reactions after a cutaneous delayed‐type hypersensitivity reaction to heparin preparations is independent of their molecular weight: a systematic review

  2011cites this paper
• Reacción de hipersensibilidad retardada a enoxaparina

  2010cites this paper
• Héparines : structure, propriétés pharmacologiques et activités

  2010cites this paper
• Drugs that affect blood coagulation, fibrinolysis, and hemostasis

  2010cites this paper
• [Fondaparinux and lepirudin as therapeutic alternatives in a disseminated eczematous skin reaction to low-molecular-weight heparin].

  2010cites this paper
• Fondaparinux y lepirudina como alternativas terapéuticas ante una reacción cutánea eccematosa diseminada a heparina de bajo peso molecular

  2010cites this paper
• Patch Testing in Non-Immediate Drug Eruptions

  2008cites this paper
• Allergy diagnostic testing: an updated practice parameter.

  2008cites this paper
• Provocation tests in diagnosing drug hypersensitivity.

  2008cites this paper
• Danaparoid in der Schwangerschaft bei Heparinunverträglichkeit

  2007cites this paper
• Acute generalized exanthematous pustulosis from dalteparin.

  2007cites this paper
• Delayed‐type hypersensitivity to low molecular weight heparins and heparinoids: cross‐reactivity does not depend on molecular weight

  2007cites this paper
• Haemodialysis‐associated anaphylactic and anaphylactoid reactions

  2006cites this paper
• Allergy to heparins and anticoagulants with a similar pharmacological profile: an update

  2006cites this paper
• Management of cutaneous type IV hypersensitivity reactions induced by heparin

  2006cites this paper
• Haemodialysis-associated anaphylactic and anaphylactoid

  2006cites this paper
• Heparin-induced thrombocytopenia (HIT)

  2006cites this paper
• Unexpected delayed‐type hypersensitivity skin reactions to the ultra‐low‐molecular‐weight heparin fondaparinux

  2005cites this paper
• Immediate type hypersensitivity after injection of nadroparin (Fraxiparin)

  2005cites this paper
• Cross-reactivity among drugs: clinical problems.

  2005cites this paper
• Accidents iatrogènes liés à l'héparinothérapie

  2005cites this paper
• Reacciones cutáneas a heparinas de bajo peso molecular

  2004cites this paper
• Hypersensitivity to Nadroparin Calcium

  2004cites this paper
• Dermatoscopic and histopathological diagnosis of primary and metastatic melanoma: report of a workshop at the Third Research Meeting on Melanoma, Milan, Italy, May 2003.

  2004cites this paper
• Treatment of 51 pregnancies with danaparoid because of heparin intolerance

  2004cites this paper
• Anaphylaxis During the Perioperative Period

  2003cites this paper
• Eczematous plaques related to unfractionated and low-molecular-weight heparin in pregnancy: cross-reaction with danaparoid sodium.

  2003cites this paper
• Delayed‐type hypersensitivity skin reactions due to heparins and heparinoids. Tolerance of recombinant hirudins and of the new synthetic anticoagulant fondaparinux

  2003cites this paper
• Generalized eczema induced by nadroparin.

  2003cites this paper
• The use of intravenous recombinant hirudin in the treatment of deep vein thrombosis in a patient with an acute heparin allergy.

  2002cites this paper
• Placas eritematosas en áreas de inyección de heparina

  2002cites this paper
• The role of skin testing in drug eruptions

  2002cites this paper
• Le rôle des tests cutanés dans la toxidermie

  2002cites this paper
• Anticoagulant-related skin reactions

  2002cites this paper
• Different patterns of cross‐reactivity in non‐immediate hypersensitivity to heparins: from localized to systemic reactions

  2002cites this paper
• The use of low-molecular-weight heparin for the management of venous thromboembolism in pregnancy.

  2002cites this paper
• Placas eritematosas por heparina de bajo peso molecular

  2001influential citation
• Pharmacology of low molecular weight heparins.

  2001cites this paper
• Delayed‐Type Hypersensitivity and Cross‐Reactivity to Heparins and Danaparoid: A Prospective Study

  2001cites this paper